Literature DB >> 25456126

Independent component analysis uncovers the landscape of the bladder tumor transcriptome and reveals insights into luminal and basal subtypes.

Anne Biton1, Isabelle Bernard-Pierrot2, Yinjun Lou2, Clémentine Krucker2, Elodie Chapeaublanc2, Carlota Rubio-Pérez3, Nuria López-Bigas4, Aurélie Kamoun2, Yann Neuzillet5, Pierre Gestraud6, Luca Grieco6, Sandra Rebouissou2, Aurélien de Reyniès7, Simone Benhamou8, Thierry Lebret9, Jennifer Southgate10, Emmanuel Barillot6, Yves Allory11, Andrei Zinovyev6, François Radvanyi12.   

Abstract

Extracting relevant information from large-scale data offers unprecedented opportunities in cancerology. We applied independent component analysis (ICA) to bladder cancer transcriptome data sets and interpreted the components using gene enrichment analysis and tumor-associated molecular, clinicopathological, and processing information. We identified components associated with biological processes of tumor cells or the tumor microenvironment, and other components revealed technical biases. Applying ICA to nine cancer types identified cancer-shared and bladder-cancer-specific components. We characterized the luminal and basal-like subtypes of muscle-invasive bladder cancers according to the components identified. The study of the urothelial differentiation component, specific to the luminal subtypes, showed that a molecular urothelial differentiation program was maintained even in those luminal tumors that had lost morphological differentiation. Study of the genomic alterations associated with this component coupled with functional studies revealed a protumorigenic role for PPARG in luminal tumors. Our results support the inclusion of ICA in the exploitation of multiscale data sets.
Copyright © 2014 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25456126     DOI: 10.1016/j.celrep.2014.10.035

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  74 in total

1.  Loss of FOXA1 Drives Sexually Dimorphic Changes in Urothelial Differentiation and Is an Independent Predictor of Poor Prognosis in Bladder Cancer.

Authors:  Opal L Reddy; Justin M Cates; Lan L Gellert; Henry S Crist; Zhaohai Yang; Hironobu Yamashita; John A Taylor; Joseph A Smith; Sam S Chang; Michael S Cookson; Chaochen You; Daniel A Barocas; Magdalena M Grabowska; Fei Ye; Xue-Ru Wu; Yajun Yi; Robert J Matusik; Klaus H Kaestner; Peter E Clark; David J DeGraff
Journal:  Am J Pathol       Date:  2015-05       Impact factor: 4.307

Review 2.  Genomic Subtyping in Bladder Cancer.

Authors:  Tuomas Jalanko; Joep J de Jong; Ewan A Gibb; Roland Seiler; Peter C Black
Journal:  Curr Urol Rep       Date:  2020-03-13       Impact factor: 3.092

3.  Learning common and specific patterns from data of multiple interrelated biological scenarios with matrix factorization.

Authors:  Lihua Zhang; Shihua Zhang
Journal:  Nucleic Acids Res       Date:  2019-07-26       Impact factor: 16.971

4.  Distinct Lipidomic Landscapes Associated with Clinical Stages of Urothelial Cancer of the Bladder.

Authors:  Danthasinghe Waduge Badrajee Piyarathna; Thekkelnaycke M Rajendiran; Vasanta Putluri; Venkatrao Vantaku; Tanu Soni; Friedrich-Carl von Rundstedt; Sri Ramya Donepudi; Feng Jin; Suman Maity; Chandrashekar R Ambati; Jianrong Dong; Daniel Gödde; Stephan Roth; Stephan Störkel; Stephan Degener; George Michailidis; Seth P Lerner; Subramaniam Pennathur; Yair Lotan; Cristian Coarfa; Arun Sreekumar; Nagireddy Putluri
Journal:  Eur Urol Focus       Date:  2017-04-20

Review 5.  Toward personalized management in bladder cancer: the promise of novel molecular taxonomy.

Authors:  Marie-Lisa Eich; Lars Dyrskjøt; George J Netto
Journal:  Virchows Arch       Date:  2017-04-21       Impact factor: 4.064

6.  Commensal Microbiota Promote Lung Cancer Development via γδ T Cells.

Authors:  Chengcheng Jin; Georgia K Lagoudas; Chen Zhao; Susan Bullman; Arjun Bhutkar; Bo Hu; Samuel Ameh; Demi Sandel; Xu Sue Liang; Sarah Mazzilli; Mark T Whary; Matthew Meyerson; Ronald Germain; Paul C Blainey; James G Fox; Tyler Jacks
Journal:  Cell       Date:  2019-01-31       Impact factor: 41.582

7.  Trends and disparities in the use of neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma.

Authors:  Jonathan J Duplisea; Ross J Mason; Chad A Reichard; Roger Li; Yu Shen; Stephen A Boorjian; Colin P Dinney
Journal:  Can Urol Assoc J       Date:  2018-07-31       Impact factor: 1.862

8.  Identification of hub genes and pathways associated with bladder cancer based on co-expression network analysis.

Authors:  Dong-Qing Zhang; Chang-Kuo Zhou; Shou-Zhen Chen; Yue Yang; Ben-Kang Shi
Journal:  Oncol Lett       Date:  2017-05-26       Impact factor: 2.967

9.  Genomic Activation of PPARG Reveals a Candidate Therapeutic Axis in Bladder Cancer.

Authors:  Jonathan T Goldstein; Ashton C Berger; Juliann Shih; Fujiko F Duke; Laura Furst; David J Kwiatkowski; Andrew D Cherniack; Matthew Meyerson; Craig A Strathdee
Journal:  Cancer Res       Date:  2017-09-18       Impact factor: 12.701

10.  Sonic Hedgehog and WNT Signaling Promote Adrenal Gland Regeneration in Male Mice.

Authors:  Isabella Finco; Antonio M Lerario; Gary D Hammer
Journal:  Endocrinology       Date:  2018-02-01       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.